Highlights BioSyent Inc.

Equities

RX

CA0906901081

Market Closed - Toronto S.E. Other stock markets 03:59:59 2024-04-26 pm EDT			5-day change	1st Jan Change
8.51 ^CAD	0.00%		+0.12%	-7.70%

Apr. 22	BioSyent Inc.(TSXV:RX) dropped from S&P/TSX Venture Composite Index	CI
Apr. 01	BioSyent To Present At LD Micro New York Investor Conference	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Tranche Update on BioSyent Inc. (TSXV:RX)'s Equity Buyback Plan announced on December 13, 2022.	Mar. 13	CI
Tranche Update on BioSyent Inc. (TSXV:RX)'s Equity Buyback Plan announced on December 13, 2023.	Mar. 13	CI
BioSyent Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 13	CI
BioSyent Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 13	CI
BioSyent Inc. Seeks Acquisitions	Mar. 12	CI
Ex-dividend day	Feb. 27	FA
BioSyent Declares First Quarter 2024 Dividend	Feb. 06	MT
BioSyent Inc. Declares First Quarter 2024 Dividend, Payable on March 15, 2024	Feb. 06	CI
BioSyent Inc.'s Equity Buyback announced on December 13, 2022, has expired with 380,000 shares, representing 3.17% for CAD 2.89 million.	Dec. 17	CI
BioSyent Inc. (TSXV:RX) announces an Equity Buyback for 650,000 shares, representing 5.53% of its issued share capital.	Dec. 13	CI
BioSyent Inc. authorizes a Buyback Plan.	Dec. 12	CI
Ex-dividend day	Nov. 28	FA
Biosyent Reports Q3 2023 Results	Nov. 16	MT
Tranche Update on BioSyent Inc. (TSXV:RX)'s Equity Buyback Plan announced on December 13, 2022.	Nov. 16	CI
BioSyent Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 16	CI
BioSyent Inc. Declares Fourth Quarter 2023 Dividend, Payable on December 15, 2023	Nov. 15	CI
Ex-dividend day	23-08-29	FA
Tranche Update on BioSyent Inc. (TSXV:RX)'s Equity Buyback Plan announced on December 13, 2022.	23-08-22	CI
BioSyent Posts Higher Q2 Net Income, Revenue YOY	23-08-22	MT
BioSyent Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights BioSyent Inc.

Equities

RX

CA0906901081

Highlights

Filters